Werner syndrome RecQ helicase-IN-3 is a potent and orally active inhibitor of werner syndrome RecQ helicase with an IC50 value of 0.06 µM, exhibiting strong antiproliferative and anticancer activity, and serving as a targeted probe for studying WRN-dependent DNA repair mechanisms and synthetic lethal strategies in oncology research.
Molekulargewicht:
687.07
Reinheit:
99.60%
CAS Nummer:
[2869954-98-1]
Formel:
C31H30ClF3N8O5
Target-Kategorie:
DNA/RNA Synthesis
T72109
T72109
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten